Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 10, 2020

SELL
$1.66 - $2.73 $127,820 - $210,210
-77,000 Closed
0 $0
Q1 2020

May 21, 2020

BUY
$1.35 - $4.05 $103,950 - $311,850
77,000 New
77,000 $193,000
Q4 2019

Feb 14, 2020

SELL
$2.3 - $4.6 $90,850 - $181,700
-39,500 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$6.7 - $9.13 $264,650 - $360,635
39,500 New
39,500 $348,000
Q1 2019

May 15, 2019

SELL
$5.7 - $8.73 $108,094 - $165,555
-18,964 Closed
0 $0
Q4 2018

Feb 14, 2019

SELL
$5.04 - $10.28 $428 - $873
-85 Reduced 0.45%
18,964 $115,000
Q3 2018

Nov 09, 2018

BUY
$7.12 - $12.44 $605 - $1,057
85 Added 0.45%
19,049 $179,000
Q4 2017

Feb 14, 2018

BUY
$5.6 - $9.9 $106,198 - $187,743
18,964 New
18,964 $176,000
Q3 2017

Nov 14, 2017

SELL
$4.73 - $6.16 $99,330 - $129,360
-21,000 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
21,000
21,000 $135,000

Others Institutions Holding VRAY

About ViewRay, Inc.


  • Ticker VRAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 181,010,000
  • Market Cap $1.81M
  • Description
  • ViewRay, Inc. designs, manufactures, and markets magnetic resonance imaging (MRI) guided radiation therapy systems to image and treat cancer patients in the United States, France, Taiwan, the United Kingdom, and internationally. The company provides MRIdian, which is an MRI guided radiation therapy system that addresses beam distortion, skin tox...
More about VRAY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.